SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (1666)7/7/1999 6:17:00 AM
From: Maurice Winn1 Recommendation  Read Replies (1) of 1762
 
Don, it's interesting that IDEC can reach $86 per share and this thread draws no comment. Not even "Wheeeee!!!!"

I suppose there are few SI shareholders in it. It seems odd to me.

Meanwhile, I guess you are one, so congratulations on enjoying some recognition of serious value [assuming you still hold your stock - assuming of course that you had some].

I suppose this means that Rituxan is helping a lot of people and Y2B8 has great prospects too.

Maurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext